KE2635A - New azepine derivative, its preparation and composition containing it - Google Patents

New azepine derivative, its preparation and composition containing it

Info

Publication number
KE2635A
KE2635A KE2635*UA KE263576A KE2635A KE 2635 A KE2635 A KE 2635A KE 263576 A KE263576 A KE 263576A KE 2635 A KE2635 A KE 2635A
Authority
KE
Kenya
Prior art keywords
preparation
composition containing
azepine derivative
new azepine
new
Prior art date
Application number
KE2635*UA
Other languages
English (en)
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of KE2635A publication Critical patent/KE2635A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • C07D223/24Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom
    • C07D223/28Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom having a single bond between positions 10 and 11

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
KE2635*UA 1969-03-10 1976-05-31 New azepine derivative, its preparation and composition containing it KE2635A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH358369A CH500196A (de) 1969-03-10 1969-03-10 Verfahren zur Herstellung von neuen Azepinderivaten

Publications (1)

Publication Number Publication Date
KE2635A true KE2635A (en) 1976-06-11

Family

ID=4259115

Family Applications (1)

Application Number Title Priority Date Filing Date
KE2635*UA KE2635A (en) 1969-03-10 1976-05-31 New azepine derivative, its preparation and composition containing it

Country Status (24)

Country Link
US (2) US3642775A (de)
AT (1) AT298492B (de)
BE (1) BE747085A (de)
BG (1) BG17576A3 (de)
BR (1) BR7017332D0 (de)
CA (1) CA920586A (de)
CH (1) CH500196A (de)
CS (1) CS154294B2 (de)
DE (1) DE2011087C3 (de)
DK (1) DK125649B (de)
ES (1) ES377279A1 (de)
FI (1) FI50523C (de)
FR (1) FR2034781B1 (de)
GB (1) GB1310571A (de)
HK (1) HK51976A (de)
IE (1) IE34046B1 (de)
IL (1) IL34026A (de)
KE (1) KE2635A (de)
MY (1) MY7600194A (de)
NL (1) NL162904C (de)
NO (1) NO130314B (de)
PL (1) PL80549B1 (de)
SE (1) SE349301B (de)
YU (1) YU33862B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI75561C (fi) * 1979-10-30 1988-07-11 Ciba Geigy Ag Foerfarande foer framstaellning av 5- karbamoyl-10-oxo-10,11-dihydro-5h-dibens/b,f/azepin och daertill noedvaendiga mellanprodukter.
EP0108715A1 (de) * 1982-10-15 1984-05-16 Ciba-Geigy Ag Dibenzazepincarboxamide
FR2700117B1 (fr) * 1993-01-07 1995-02-03 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
US5472714A (en) * 1993-09-08 1995-12-05 Ciba-Geigy Corporation Double-layered oxcarbazepine tablets
IT1272897B (it) * 1995-01-13 1997-07-01 I F C Iniziative Finanziaarie Processo per la produzione di 10-oxo-10,11-diidro-sh- -dibenz(b,f) azepin-5-carbossiammide
PT101732B (pt) * 1995-06-30 1997-12-31 Portela & Ca Sa Novas di-hidrodibenzo<b,f>azepinas substituidas processo para a sua preparacao composicoes farmaceuticas que as contem e utilizacao dos novos compostos na preparacao de composicoes farmaceuticas empregues em doencas do sistema nervoso
PT101876B (pt) * 1996-05-27 1999-09-30 Portela & Ca Sa Novos derivados de 10,11-di-hidro-10-oxo-5h-dibenzo(b,f)azepina-5-carboxamida
US20020022056A1 (en) * 1997-02-14 2002-02-21 Burkhard Schlutermann Oxacarbazepine film-coated tablets
DE59902734D1 (de) 1998-11-25 2002-10-24 Dsm Fine Chem Austria Gmbh Verfahren zur Oxidation von Methyl-, Methylen- oder Methingruppen enthaltenden Substraten
AT406957B (de) * 1998-11-25 2000-11-27 Dsm Fine Chem Austria Gmbh Verfahren zur oxidation von methyl-, methylen- oder methingruppen enthaltenden substraten
GB9930058D0 (en) 1999-12-20 2000-02-09 Novartis Ag Organic compounds
IT1317854B1 (it) * 2000-02-25 2003-07-15 Farchemia Srl 5-ciano-10-idrossi-10,11-diidro-5h-dibenz(b,f)azepina e procedimentiper la sua preparazione e per la sua conversione in
WO2002064557A2 (en) * 2001-02-12 2002-08-22 Teva Pharmaceutical Industries Ltd. New crystal forms of oxcarbazepine and processes for their preparation
TW200501962A (en) * 2003-04-01 2005-01-16 Novartis Ag Use of carbamazepine derivatives for the treatment of agitation in dementia patients
SG146631A1 (en) 2003-09-03 2008-10-30 Novartis Ag Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep
WO2005066133A2 (en) * 2003-10-20 2005-07-21 Amoli Organics Ltd. NOVEL PROCESS FOR PREPARATION OF 10-OXO-10, 11-DIHYDRO-5H-DIBENZ [b,f]AZEPINE-5-CARBOXAMIDE (OXCARBAZEPINE) VIA INTERMEDIATE, 10-METHOXY-5H-DIBENZ[b,f] AZEPINE-5-CARBONYLCHLORIDE
ITMI20040452A1 (it) * 2004-03-09 2004-06-09 Clariant Lsm Italia Spa Processo per la preparazione di oxcarbazepina
US7459553B2 (en) * 2004-03-11 2008-12-02 Glenmark Generics Ltd. Process for the preparation of carboxamide compounds
WO2005096709A2 (en) * 2004-03-11 2005-10-20 Sun Pharmaceutical Industries Limited A process for the preparation of 10,11-dihydro-10-oxo-5h-dibenz[b,f]azepine-5-carboxamide
EP1600443A1 (de) * 2004-05-26 2005-11-30 Alberto Milanese Verfahren zur Herstellung von Oxcarbazepin
CA2471666C (en) * 2004-06-18 2009-10-13 Apotex Pharmachem Inc. An improved process for the preparation of oxcarbazepine and related intermediates
US20060252745A1 (en) 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
ATE496623T1 (de) 2006-04-26 2011-02-15 Supernus Pharmaceuticals Inc Oxcarbazepin-zubereitungen für kontrollierte freisetzung mit sigmoidalem freisetzungsprofil
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies
US20090082335A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched oxcarbazepine
WO2009073154A1 (en) 2007-11-28 2009-06-11 Nektar Therapeutics Al, Corporation Oligomer-tricyclic conjugates
US8530647B2 (en) * 2008-05-08 2013-09-10 Mylan Laboratories Limited Process for the preparation of oxcarbazepine
WO2011091050A1 (en) 2010-01-19 2011-07-28 Nektar Therapeutics Oligomer-tricyclic conjugates
US20150232426A1 (en) 2012-09-26 2015-08-20 Ranbaxy Laboratories Limited Process for the preparation of oxcarbazepine and its use as intermediate in the preparation of eslicarbazepine acetate
AU2016381366A1 (en) 2015-12-30 2018-06-28 Adamas Pharmaceuticals, Inc. Methods and compositions for the treatment of seizure-related disorders
PT3554490T (pt) 2016-12-16 2022-03-17 Idorsia Pharmaceuticals Ltd Combinação farmacêutica compreendendo um bloqueador de canais de cálcio de tipo t
US10639313B2 (en) 2017-09-01 2020-05-05 Ndsu Research Foundation Compound for inhibition of delta-5-desaturase (D5D) and treatment of cancer and inflammation
MX2021003730A (es) 2018-09-28 2021-06-18 Univ Griffith Agentes y métodos para modular la actividad patógena.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH403767A (de) * 1961-06-09 1965-12-15 Geigy Ag J R Verfahren zur Herstellung von neuen N-heterocyclischen Verbindungen

Also Published As

Publication number Publication date
BE747085A (fr) 1970-09-09
HK51976A (en) 1976-08-27
NL162904B (nl) 1980-02-15
BR7017332D0 (pt) 1973-01-04
DK125649B (da) 1973-03-19
FI50523B (de) 1975-12-31
PL80549B1 (de) 1975-08-30
CS154294B2 (de) 1974-03-29
IL34026A (en) 1972-12-29
SE349301B (de) 1972-09-25
US3716640A (en) 1973-02-13
CA920586A (en) 1973-02-06
FR2034781B1 (de) 1973-04-06
BG17576A3 (bg) 1973-11-10
MY7600194A (en) 1976-12-31
NL7003022A (de) 1970-09-14
GB1310571A (en) 1973-03-21
YU33862B (en) 1978-06-30
IE34046L (en) 1970-09-10
ES377279A1 (es) 1972-12-16
DE2011087C3 (de) 1979-08-30
NO130314B (de) 1974-08-12
IE34046B1 (en) 1975-01-08
IL34026A0 (en) 1970-05-21
FI50523C (fi) 1976-04-12
AT298492B (de) 1972-05-10
YU53670A (en) 1977-12-31
DE2011087A1 (de) 1970-09-24
NL162904C (nl) 1980-07-15
FR2034781A1 (de) 1970-12-18
CH500196A (de) 1970-12-15
US3642775A (en) 1972-02-15
DE2011087B2 (de) 1978-12-21

Similar Documents

Publication Publication Date Title
KE2635A (en) New azepine derivative, its preparation and composition containing it
IL36237A0 (en) Substituted benzylimidazolidinones,their preparation and pharmaceutical compositions containing them
IL38177A (en) 1-heterocyclylalkyl-4-phenylpiperidines,their preparation and compositions containing them
ZA704481B (en) Tetrahydropyrido-thioxanthene derivatives,compositions containing them,and preparation thereof
IL32444A0 (en) 2-arylaminoimidazolines,their preparation and pharmaceutical compositions containing them
IL37705A (en) Tricyclic iminoalkylamines,their preparation and pharmaceutical compositions containing them
IL33925A0 (en) Acetyl-guanidine derivatives,their preparation and pharmaceutical compositions containing them
IE33074B1 (en) New s-triazine-diones,their preparation and composition containing same
MY7500115A (en) Novel thiazolline derivatives, the preparation thereof and compositions containing the same
IL34947A0 (en) Pyridobenzodiazepin-6-one derivatives,their preparation and pharmaceutical compositions containing them
IL32801A0 (en) Hexahydroazepines,their preparation and pharmaceutical compositions containing them
IL35211A0 (en) 4-aryl-4-hydroxy-piperidine derivatives,their preparation and pharmaceutical compositions containing them
IL35779A (en) 4-amino-quinazoline derivatives,their preparation and pharmaceutical compositions containing them
IL38406A0 (en) New triazenes,their preparation and pharmaceutical compositions containing them
IL38440A0 (en) Substituted dioxypiperidines,their preparation and pharmaceutical compositions containing them
IL33624A0 (en) 1-pyridyl-2-imidazolones,their preparation and pharmaceutical compositions containing them
CA920060A (en) Flavor composition
IL33993A0 (en) Aminopropiophenones,their preparation and pharmaceutical compositions containing them
IL32699A0 (en) 6-substituted-13-polycarbonalkyl-18,19-dinorpregn-4-en-3-ones,their preparation and pharmaceutical compositions containing them
IL31987A0 (en) Benzodiazocines,their preparation and pharmaceutical composition containing them
IL32088A0 (en) Benzodiazepindiones,their preparation and pharmaceutical compositions containing them
IL32705A0 (en) Acylphenyl-alkylamines,their preparation and pharmaceutical compositions containing them
IL31909A0 (en) Substituted 3-amino-4-halogen-sydnonimines,their preparation and pharmaceutical composition containing them
IL34690A0 (en) New cardenolide-glycosides,their preparation and pharmaceutical compositions containing them
IL33630A0 (en) New benzohydroxamates,their preparation and acaricidal compositions containing them